Can Amprius Technologies (AMPX) Stock Reach $22?

Key Takeaways

• The central $22 stock price target is the arithmetic mean of six verified, current analyst price targets, rounded from roughly $22.17.
• At a recent price near $7.59, reaching $22 would require an upside of about 190% — a very large move.
• Individual analyst targets range from $14 to $30, a wide spread that reflects genuine disagreement about execution and valuation.
• Bullish support rests on a $74.8 million U.S. Department of War grant, rising revenue guidance, and growing defense and drone demand.
• The biggest risks are heavy customer concentration, losses and cash burn, and a premium valuation on a sales basis.

Analyst Price Targets and Consensus View

Amprius Technologies, Inc. (AMPX) is covered by a group of analysts who have issued current, individually attributable price targets. Reviewing six verifiable targets yields the following: Canaccord Genuity at $14 (initiated October 2026), H.C. Wainwright at $18 (September 2026), Roth MKM at $22 (September 2026), Northland Securities at $24 (September 2026), Cantor Fitzgerald at $25 (September 2026), and Clear Street at $30 (lowered from $33 in August 2026). The arithmetic mean of these six figures is about $22.17, rounded to a $22 central target. The approximate low-to-high range is $14 to $30.

Independent aggregators report slightly different counts — roughly 11 to 13 analysts — with average price targets near $21 to $22 and a low of $14, underscoring that the calculated mean should not be read as a published official consensus. Nearly all current ratings are Buy or Overweight, but the wide range shows analysts differ on how quickly Amprius can scale its silicon-anode battery technology profitably.

Current Market Position and Path Toward the Target

Amprius shares closed near $7.59 in mid-October 2026, toward the bottom of a 52-week range of roughly $7.29 to $24.23. Reaching $22 implies a gain of about 190% from that level — a very large move requiring a near-tripling of the share price. The stock has already pulled back sharply, declining by roughly two-thirds from its peak, so the target represents a recovery to levels the shares traded at earlier in 2026 rather than an unprecedented valuation milestone.

The path toward $22 would likely depend on sustained revenue growth, progress converting grants and tolling capacity into production, and expanding gross margins. With trailing revenue around $109 million and a net loss over the trailing twelve months, investors are pricing a multi-year growth story rather than near-term profitability.

What Could Support a Move Toward the Target

• A U.S. Department of War grant of up to $74.8 million to retrofit an existing battery line into NDAA-compliant (National Defense Authorization Act) high-energy-density pouch cells for drones, targeting roughly 12 million cells annually by early 2028.
• Management estimates the converted line could add around $150 million of incremental annual revenue at full capacity.
• Fiscal 2026 guidance was raised for a second consecutive quarter, to at least $140 million in revenue and at least $4 million in adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization).
• Strong recent execution, including roughly 126% revenue growth in the June 2026 quarter and near break-even adjusted EBITDA.
• Repeat orders and new wins in unmanned aerial systems, supported by earlier Defense Innovation Unit strategic funding.

What Could Prevent the Target From Being Reached

• Heavy concentration in aviation and drone demand, which makes results sensitive to order timing and program decisions.
• Execution risk in scaling silicon-anode production from pilot volumes to high-volume manufacturing without cost or reliability setbacks.
• Ongoing net losses and negative free cash flow, with a need to fund expansion despite a strong cash position and minimal debt.
• A premium valuation on a sales basis — the stock has traded well above the industry average price-to-sales multiple — that could compress if sentiment cools or peers de-rate further.
• High volatility, reflected in a five-year beta around 2.35, and insider selling activity that can weigh on confidence.

Technical Levels and Market Structure

Amprius trades near its 52-week low of about $7.29, which now functions as a key support level after a multi-month decline from a 52-week high near $24.23. A durable move toward $22 would first require reclaiming intermediate resistance around prior breakdown zones in the low-to-mid teens. The $24 area — near the former high — is a meaningful longer-term level, while the psychological $10 and $20 marks may act as waypoints for sentiment. The stock's sharp correction and elevated beta suggest any recovery path is likely to be volatile.

Time Horizon and What Investors Should Monitor

Most analyst price targets reflect a research horizon of roughly 12 months, though individual firms apply different valuation methods and timeframes — Roth MKM, for example, based its $22 target on roughly nine times a 2028 revenue estimate, while Clear Street cited conviction in its 2027–2029 revenue forecasts. Investors should monitor the next earnings report (scheduled for early November 2026), revenue guidance updates, adjusted EBITDA progress, production qualification milestones, new customer and partnership announcements, and any further government funding. Changes in analyst targets and valuation multiples across the battery and defense-technology peer group also matter.

AI Daily Buy/Sell Signals

For traders seeking an efficient way to track changing conditions across thousands of stocks and ETFs, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor markets and generate Buy, Sell, or Hold signals based on shifting market behavior, technical patterns, and AI-driven analysis. The tool is designed to help users discover opportunities, monitor existing positions, and spot evolving trends more efficiently than manual screening. Because signals update with market conditions, they can complement fundamental research on volatile names like Amprius Technologies. Traders can explore these signals to keep pace with rapidly changing technical and sentiment shifts.

Final Assessment

The $22 central target for Amprius Technologies is an analyst-derived figure — the rounded mean of six current, verifiable price targets spanning $14 to $30 — and it sits far above the recent price near $7.59, implying a very large required move of roughly 190%. The bull case is anchored in a meaningful defense grant, accelerating revenue guidance, and expanding demand for high-energy-density batteries in drone and aviation applications. The bear case rests on concentrated demand, persistent losses and cash burn, a premium valuation, and elevated volatility. With analyst views spread across a wide range and no certainty around execution, investors should weigh the growth opportunity against the execution and valuation risks rather than treat the average target as a likely outcome.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations